Cell Therapy for Type 1 Diabetes: Vertex Trial ...

By Rene Pretorius

June 23, 2025

Cell therapy for type 1 diabetes (T1D) offers hope for restoring insulin production in a condition where autoimmune de...
ACIP Vaccine Policy Concerns
NICE Rejects Donanemab: Treatment Cost-Effectiveness
How Gene-Editing Therapies Are Revolutionizing ASCVD Treatment and Market Tra...
EMA 2024 Report Highlights: Innovations in Medicine Approval and Regulatory A...
PCV20 Reimbursement Guidelines: Analysis of Dutch Advisory Council Recommenda...
NICE Approves Transformative Multiple Myeloma Treatment
KEYTRUDA Head Neck Cancer Approval: Transforming Treatment and Health Economics
EHK Clusters 2026 Report: Enhancements in Dutch Risk Equalization for High-Co...
Telemedicine Growth Strategies: Insights from the WHO European Region
Pfizer Conference Insights: Analyzing Bourla’s Strategic Vision Amid Po...
RFK Jr.’s ACIP Overhaul: Examining Vaccine Policy Implications
Elsa – FDA AI Tool: Navigating Efficiency and Ethics